ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
QuidelOrtho Corp
Raw
QuidelOrtho Corp
QDEL
時価総額
$16.5億
PER
体外診断(IVD)とPOC診断の最大手。SofiaやTriageのPOC機器とVirenaのクラウド監視システムを展開。2022年の合併で取引費用4,690万ドル計上。米国・欧州中心に130カ国超で展開。
マイリストに追加
マイリストに追加
概要
財務
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
2023年
1月1日
2023年
12月31日
2024年
12月29日
Net (loss) income
549
-10
-2,052
Depreciation and amortization
284
457
453
Goodwill, Impairment Loss
-
-
1,823
Asset impairment charge
-
-
57
Stock-based compensation expense
48
52
42
Change in deferred tax assets and liabilities
-
-
-99
Change in operating lease right-of-use assets and liabilities
18
-
-0
Payment of accreted interest on contingent and deferred consideration
10
10
-
Loss on extinguishment of debt
-24
-
-
Unwind inventory fair value adjustment
61
-
-
Asset write off
-
-
20
Other non-cash, net
-35
-14
-2
Accounts receivable
-150
-160
-5
Inventories
117
212
134
Prepaid expenses and other current and non-current assets
26
27
10
Accounts payable
24
3
-23
Accrued payroll and related expenses
18
-54
35
Income taxes payable
-27
-60
-9
Other current and non-current liabilities
-75
-6
-23
Net cash provided by operating activities
885
280
83
Acquisitions of property, plant, equipment, investments and intangibles
141
209
195
Proceeds from Sale, Property, Held-for-Sale
-
-
9
Acquisition of businesses, net of cash and restricted cash acquired
1,511
-
-
Proceeds from government assistance allocated to fixed assets
18
14
-
Purchases of marketable securities
64
60
7
Proceeds from sale of marketable securities
53
78
63
Other payments
-
10
20
Net cash used for investing activities
-1,644
-188
-150
Proceeds from issuance of common stock
26
12
5
Short-term borrowings, net
-
2
-2
Revolving credit facility, net
-
-
198
Proceeds from Debt, Net of Issuance Costs
2,735
-
-
Payments on long-term borrowings and extinguishment costs
2,388
228
143
Payments of tax withholdings related to vesting of stock-based awards
9
14
10
Repurchases of common stock
74
7
-
Principal payments of acquisition contingent consideration
4
-
-
Principal payments of deferred consideration
34
30
-
Net cash provided by (used for) financing activities
252
-266
49
Effect of exchange rates on cash
-2
-1
-3
Net decrease in cash, cash equivalents and restricted cash
-509
-174
-21
Cash paid during the period for interest
95
150
178
Income Taxes Paid
265
87
42
Noncash or Part Noncash Acquisition, Fixed Assets Acquired
40
41
26
Transfer of instrument inventories to fixed assets
74
155
149
Stock Issued
-
-
0
Finance Lease Asset and Liability, Initial Recognition
-
-
13